Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB

In this episode, we're joined by Dr. Richard Menzies and Dr. Jonathan Campbell from the McGill Respiratory Epidemiology and Clinical Research Unit to discuss the results of their multi-center RCT comparing 4 months of rifampin to 9 months of isoniazid for the treatment of latent TB. Their findings are outlined in two papers, entitled "Four Months of Rifampin or Nine Months of Isoniazid for Latent TB in Adults" and "Safety and Side Effects of Rifampin Versus Isoniazid in Children" published in the August 2018 issue of the New England Journal of Medicine.

You can listen to Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 4 - Dr. Richard Menzies and Dr. Jonathan Campbell - 4 months of Rifampin for latent TB is an episode from Mcgill University Medical Podcast Series by Mcgill University Medical Podcast Series.

This episode is 00:18:48 long.

This episode was published on Feb 9, 2019.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Mcgill University Medical Podcast Series when more episodes are available from the podcast feed.